Lineage tracing of alpha-to-beta cell transition after injection of Wnt pathway-stimulated human multipotent stromal cell-secreted proteins

Clicks: 1
ID: 339135
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #72 of 73 articles by views in stem cells international

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Diabetes is projected to affect >600 million people by 2045. Although life-saving insulin therapy can manage hyperglycemia, exogenous insulin is not a cure for diabetes, and life-expectancy for those affected is reduced by 10-15 years. Regenerative therapies aimed at replenishing functional beta cell mass have gained interest. However, the cellular mechanisms that mediate islet regeneration remain unclear. We have shown that human bone marrow-derived multipotent stromal cells (MSC), licenced by WNT-pathway activation using CHIR99021 (CHIR), secrete factors (CHIR CdM) that promote beta-cell recovery in streptozotocin (STZ)-treated immunodeficient NOD/SCID mice. Here, we investigated whether this regeneration involved alpha-to-beta cell conversion, using a Glucagon-iCre;Rosa26-TdTomato (GcgXTdT) lineage-tracing model. Following hyperglycemia induction with STZ and intrapancreatic injection of CHIR CdM, TdTomato+/insulin+ cells were transiently increased within 4 days of injection, indicating alpha cell plasticity and acquisition of insulin expression. CHIR CdM injection also increased the abundance and proliferation of insulin+ cells at day 28. Additionally, CHIR CdM injection altered infiltrating pancreatic immune cell composition, including increased CD4+ and CD68+ cells. Together, these findings demonstrate that intrapancreatic administration of a single injection of CHIR CdM initiates a regenerative response characterized by alpha-to-beta cell plasticity, insulin+ cell-proliferation, and immune remodeling in immune competent GcgxTdT mice. While additional regenerative stimuli may be required for beta cell maturation to restore glycemic control, understanding the mechanisms by which pancreatic beta cell regeneration is initiated in the presence of immune cells may help inform therapies for the treatment of diabetes.
Reference Key
openalex_W7225384780 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ajaya Sharma, Gillian I. Bell, Nouran N. Al-Banaa, Kushvir Saini, Caleb Podgers, Anargyros Xenocostas, David A Hess
Are you one of these authors? Claim your profile
Journal stem cells international
Year 2026
DOI
10.1093/stmcls/sxag061
URL
https://doi.org/10.1093/stmcls/sxag061
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.